These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21078937)

  • 21. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
    Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates.
    Choi MJ; Won EJ; Shin JH; Kim SH; Lee WG; Kim MN; Lee K; Shin MG; Suh SP; Ryang DW; Im YJ
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3653-61. PubMed ID: 27044550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.
    Ge SH; Wan Z; Li J; Xu J; Li RY; Bai FY
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3126-31. PubMed ID: 20516286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D; Ischer F; Koymans L; Bille J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
    MacCallum DM; Coste A; Ischer F; Jacobsen MD; Odds FC; Sanglard D
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1476-83. PubMed ID: 20086148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanisms of Azole Resistance in Four Clinical
    Shi H; Zhang Y; Zhang M; Chang W; Lou H
    Microb Drug Resist; 2021 Dec; 27(12):1641-1651. PubMed ID: 34037478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates.
    Xu Y; Sheng F; Zhao J; Chen L; Li C
    Arch Microbiol; 2015 Nov; 197(9):1087-93. PubMed ID: 26349561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole.
    Morais Vasconcelos Oliveira J; Conceição Oliver J; Latércia Tranches Dias A; Barbosa Padovan AC; Siqueira Caixeta E; Caixeta Franco Ariosa M
    Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
    Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
    Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
    Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
    Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upc2p-associated differential protein expression in Candida albicans.
    Hoehamer CF; Cummings ED; Hilliard GM; Morschhäuser J; David Rogers P
    Proteomics; 2009 Oct; 9(20):4726-30. PubMed ID: 19750515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.
    Feng LJ; Wan Z; Wang XH; Li RY; Liu W
    Chin Med J (Engl); 2010 Mar; 123(5):544-8. PubMed ID: 20367978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans.
    Sasse C; Schillig R; Dierolf F; Weyler M; Schneider S; Mogavero S; Rogers PD; Morschhäuser J
    PLoS One; 2011; 6(9):e25623. PubMed ID: 21980509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana.
    Kumar A; Nair R; Kumar M; Banerjee A; Chakrabarti A; Rudramurthy SM; Bagga R; Gaur NA; Mondal AK; Prasad R
    Folia Microbiol (Praha); 2020 Aug; 65(4):747-754. PubMed ID: 32219719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UPC2 is universally essential for azole antifungal resistance in Candida albicans.
    Vasicek EM; Berkow EL; Flowers SA; Barker KS; Rogers PD
    Eukaryot Cell; 2014 Jul; 13(7):933-46. PubMed ID: 24659578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans.
    Xiang MJ; Liu JY; Ni PH; Wang S; Shi C; Wei B; Ni YX; Ge HL
    FEMS Yeast Res; 2013 Jun; 13(4):386-93. PubMed ID: 23480635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
    Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.